Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
复制标题
DOI:
10.1016/s1470-2045(14)70409-7
复制
发表时间:
2015-03
期刊:
影响因子:
--
通讯作者:
International Late Effects of Childhood Cancer Guideline Harmonization Group
中科院分区:
文献类型:
--
作者:
Armenian SH;Hudson MM;Mulder RL;Chen MH;Constine LS;Dwyer M;Nathan PC;Tissing WJ;Shankar S;Sieswerda E;Skinner R;Steinberger J;van Dalen EC;van der Pal H;Wallace WH;Levitt G;Kremer LC;International Late Effects of Childhood Cancer Guideline Harmonization Group
Childhood cancer survivors treated with anthracycline chemotherapy or chest radiation are at an increased risk of developing congestive heart failure (CHF). In this population, CHF is well-recognized as a progressive disorder, with a variable period of asymptomatic cardiomyopathy which precedes signs and symptoms. As a result, a number of practice guidelines have been developed to facilitate detection and treatment of asymptomatic cardiomyopathy. These guidelines differ with regards to definitions of at risk populations, surveillance modality and frequency, and recommendations for interventions. These differences may hinder the effective implementation of these recommendations. We report on the results of an international collaboration to harmonize existing cardiomyopathy surveillance recommendations, using an evidence-based approach that relied on standardized definitions for outcomes of interest and transparent presentation of the quality of the evidence. The resultant recommendations were graded according to the quality of the evidence and the potential benefit gained from early detection and intervention.